Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: Comparing Moderately Ultra Hypofractionated Radiation Treatments for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating moderately ultra hypofractionated radiation schedules for post-operative prostate cancer. The study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Post-Operative Prostate Cancer | Phase 2 | Status: RECRUITING